The Trump administration seems to have dropped the $115 billion in drug-spending cuts pushed by the White House on Friday (July 19), restoring the politics of the drug-pricing debate to its previous level of complication. The White House reportedly now seeks $75 billion in separate offsets, which Bloomberg reports comprise extending budget caps on Medicare and imposing customs fees. But the $115 billion in drug-spending cuts proposed Friday are still of interest because the measures pushed by the White...